全文获取类型
收费全文 | 149401篇 |
免费 | 32526篇 |
国内免费 | 2404篇 |
专业分类
耳鼻咽喉 | 5160篇 |
儿科学 | 5368篇 |
妇产科学 | 2399篇 |
基础医学 | 3032篇 |
口腔科学 | 1468篇 |
临床医学 | 26719篇 |
内科学 | 47141篇 |
皮肤病学 | 7406篇 |
神经病学 | 14697篇 |
特种医学 | 6347篇 |
外科学 | 40850篇 |
综合类 | 258篇 |
现状与发展 | 72篇 |
预防医学 | 6996篇 |
眼科学 | 3436篇 |
药学 | 1210篇 |
中国医学 | 23篇 |
肿瘤学 | 11749篇 |
出版年
2024年 | 512篇 |
2023年 | 4777篇 |
2022年 | 1172篇 |
2021年 | 3066篇 |
2020年 | 6014篇 |
2019年 | 2139篇 |
2018年 | 7365篇 |
2017年 | 7337篇 |
2016年 | 8395篇 |
2015年 | 8414篇 |
2014年 | 15472篇 |
2013年 | 15597篇 |
2012年 | 5434篇 |
2011年 | 5450篇 |
2010年 | 10340篇 |
2009年 | 14228篇 |
2008年 | 5772篇 |
2007年 | 3994篇 |
2006年 | 6463篇 |
2005年 | 3754篇 |
2004年 | 2996篇 |
2003年 | 1993篇 |
2002年 | 2067篇 |
2001年 | 3837篇 |
2000年 | 3049篇 |
1999年 | 3246篇 |
1998年 | 3654篇 |
1997年 | 3463篇 |
1996年 | 3361篇 |
1995年 | 3214篇 |
1994年 | 1943篇 |
1993年 | 1567篇 |
1992年 | 1396篇 |
1991年 | 1414篇 |
1990年 | 1061篇 |
1989年 | 1189篇 |
1988年 | 1021篇 |
1987年 | 862篇 |
1986年 | 898篇 |
1985年 | 729篇 |
1984年 | 552篇 |
1983年 | 528篇 |
1982年 | 516篇 |
1981年 | 405篇 |
1980年 | 359篇 |
1979年 | 325篇 |
1978年 | 342篇 |
1977年 | 398篇 |
1975年 | 286篇 |
1972年 | 306篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
991.
Kann Holmén RN Doctoral Student Kjerstin Ericsson RN PhD Researcher Lars Andersson DMSc Associate Professor Bengt Winblad MD Professor 《Journal of advanced nursing》1992,17(1):43-51
The purpose was to investigate experienced loneliness among the elderly. The material included 1725 people, aged 75 and over. The study describes relationships between loneliness, social network, cognitive function and health. Thirty-five per cent experienced loneliness, and a higher percentage was found among women. A gradual increase in loneliness was found up to the age of 90, after which a levelling was found. Elderly persons living together with a partner experienced less loneliness. There were no significant differences between those with and without children. Ten per cent reported not having any friends and, of these, one out of two experienced loneliness. A high frequency of experienced loneliness was found among elderly people with reduced cognitive function. Subjectively experienced bad health and loneliness were strongly related to each other, i.e. a person who experienced loneliness did usually not feel completely healthy. 相似文献
992.
993.
Shunichi Takaya MD Shunzaburo Iwatsuki Takashi Noguchi Hisaaki Koie Iman Zaghloul Raman Venkataramanan Thomas E. Starzl 《Surgery today》1989,19(1):49-56
The influence of experimentally induced hepatic dysfunction on the pharmacokinetics of Cyclosporine A (CsA) was determined
in dogs. The pharmacokinetics of oral (PO) and intravenous (IV) CsA were studied before and after 70 per cent hepatectomy
or complete bile duct ligation (CBDL). Changes in liver function were monitored by serial measurements of serum bilirubin,
and by the maximum removal rate (Rmax) and plasma disappearance rate (ICG-K) of indocyanine green (ICG). Concentrations of
CsA in whole blood were measured by HPLC. Seventy per cent hepatectomy caused significant liver dysfunction: the ICG-Rmax
decreased by 47.7±7.1 per cent (mean±SD) and the ICG-K decreased by 61.3±9.7 per cent during the first week after hepatectomy.
At the same time, the systemic clearance (CLs) of IV-CsA decreased by 43.9±8.2 per cent, the area under the concentration
curve (AUC) of IV-CsA increased by 35.4±20.8 per cent and the bioavailability of CsA decreased by 26.4±14.8 per cent. CBDL
also induced significant liver dysfunction: the ICG-Rmax decreased by 39.1±12.8 per cent and the ICG-K decreased by 65.6±3.6
per cent in the second week after the operation. During the same period, the AUC of PO-CsA decreased by 69.9±10.7 per cent
and the bioavailability of CsA also decreased markedly by 73.9±15.6 per cent. These data indicate that hepatic impairment
significantly influences the pharmacokinetics of CsA, not only by the changes in intestinal absorption, but also by those
in hepatic, metabolism. Dose adjustment is therefore necessary in the presence of hepatic dysfunction in order to maintain
an adequate blood concentration of CsA without causing side effects.
This research was performed in the Department of Surgery, University of Pittsburgh Health Center, University of Pittsburgh,
USA 相似文献
994.
995.
Ronald R. Watson PhD Mary E. Mohs MS RD Cteamond Eskelson PhD Richard E. Samptiner MD Barbara Hartmann PhD 《Alcoholism, clinical and experimental research》1986,10(4):364-385
The prevalence and incidence of heavy alcohol consumption are major problems which have been increasing in many countries in recent years. It is crucial for physicians to consistently identify early drinking problems as well as the various end disease states in order to minimize suffering and maximize recovery. This paper reviews the evolutionary development of clinical tools for detection of alcohol abuse. The focus is primarily on clinical/biochemical indicators of alcohol abuse, emphasizing but not limited to changes in hematological characteristics, liver enzyme activity, lipids, immune function factors, hormones, neurological factors, and some physically based tests. Use of test combinations and sophisticated statistical analysis of pattern changes in test batteries evidence increased diagnostic efficiency. 相似文献
996.
997.
998.
Shuji Seki MD 《Surgery today》1987,17(2):123-129
The ratio of PaO2 to FiO2 was often low (300 or less) in four patients with complications of hyperosmolar hyperglycemic non-ketotic diabetic coma (HHNKDC)
following open heart surgery. Four of our patients had poor oxygenation and subsequent spontaneous recovery from in the immediate
post-operative period, although HHNKDC occurred only in one during this period. In the 3 others, poor oxygenation without
accompanying HHNKDC lasted for 1–6 days and HHNKDC developed about 2 weeks after open heart surgery at time when poor oxygenation
reoccurred. If a working diagnosis of congestive heart failure was made only on the basis of the most common probability,
and the fluid supply was restricted, HHNKDC would readily occur or be aggravated by the dehydration iatrogenically produced.
It is thus concluded that HHNKDC should be included in diagnoses for pulmonary dysfunction. 相似文献
999.
1000.
Tun Li Myung G. Lee Win L. Chiou 《Journal of pharmacokinetics and pharmacodynamics》1986,14(5):495-509
Effects of differences in the rate and composition of intravenous fluid replacement for urine loss on the pharmacokinetics and pharmacodynamics of furosemide were evaluated using the dog as a model animal. Each of six dogs received 8-hr constant intravenous infusion of 20 mg (15 mg used in one dog) of furosemide with 0% replacement (treatment I), 50% replacement (treatment II), and 100% replacement (treatment III) with lactated Ringer's solution, as well as with 100% replacement with 5% dextrose in water (treatment IV). Most pharmacokinetic parameters, such as plasma clearance, steady-state volume of distribution, mean residence time, and terminal half-life, were essentially the same in all four treatments. Renal clearances and urinary excretion rates of the drug in treatments II–IVwere essentially the same, but about 20% higher than those in treatment I.In spite of the similarities in kinetic properties, diuretic and/or natriuretic effects from furosemide were markedly different among the four treatments. For example, mean 10-hr urine outputs were 646, 1046, 3156, and 1976 ml and mean 10-hr sodium excretions were 87.0, 142, 383, and 97.2 mmole for treatments I–IV,respectively. Except for treatment III,diuresis and/or natriuresis were found to be time-dependent, generally decreasing with time until reaching a low plateau during later hours of infusion. The present findings also showed that (1)no fluid replacement and 100% replacement with 5% dextrose solution both produced the same degree of severe acute tolerance in natriuresis, indicating the insignificance of water compensation in tolerance development; (2)in treatment II,where neutral sodium balance was achieved, the development of acute tolerance in diuresis and natriuresis can mainly be attributed to negative water balance under this special condition; (3)at steady state the hourly diuresis and natriuresis could differ up to about ten times between treatments. Some implications for the kinetic/dynamic relationship or modeling, in the clinical use, and in the bioequivalence evaluation of dosage forms are discussed. 相似文献